A clinical researcher is evaluating a subunit vaccine designed to protect individuals against the bacterium Neisseria meningitidis (which causes meningitis). The vaccine contains purified antigens from the surface of the bacterium.
Explain how exposure to this vaccine stimulates the human immune system to destroy these antigens and provides long-term active immunity against future infections by the live Neisseria meningitidis bacterium.
